FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/02/040534 [Registered on: 23/02/2022] Trial Registered Prospectively
Last Modified On: 22/02/2022
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   "A Clinical Study of Alambushadi Churna and Shatyadi Kashay in patients of Amvata vis a vis Rheumatoid Arthritis" 
Scientific Title of Study   "A Clinical Study of Alambushadi Churna and Shatyadi Kashay in patients of Amvata vis-a-vis Rheumatoid Arthritis" 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Priyanka Yadav  
Designation  Ph.D Scholar 
Affiliation  Shri krishna Ayush University Kurukshetra Haryana 
Address  Room no. 55 56 first floor Department of Kayachikitsa Shri krishna Ayush University Kurukshetra Haryana

Kurukshetra
HARYANA
136118
India 
Phone  7054236800  
Fax    
Email  pinkdeep55@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr Balbir Singh 
Designation  Professor & Head 
Affiliation  Shri Krishna Ayush University Kurukshetra 
Address  Room no. 55 56 first floor Department of Kayachikitsa Shri krishna Ayush University Kurukshetra Haryana

Kurukshetra
HARYANA
136118
India 
Phone  9813063424  
Fax    
Email  balbirsandhu63@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Annada Prasad Nayak 
Designation  Associate Professor 
Affiliation  MSM Institute of Ayurveda Khanpur Kalan Sonepat Haryana  
Address  MSM Institute of Ayurveda BPS Mahila Viswavidyalya Khanpur Kalan Sonipat Haryana

Sonipat
HARYANA
131305
India 
Phone  09355506222  
Fax    
Email  vd_apnayak@rediffmail.com  
 
Source of Monetary or Material Support  
Shri Krishna Ayush University Kurukshetra Haryana 
 
Primary Sponsor  
Name  Department of Kayachikitsa Shri Krishna Ayush University Kurukshetra Haryana 
Address  Shri Krishna Ayush University Kurukshetra Haryana PIN 136118 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Priyanka yadav  MLR ayurveda college and Hospital   Room no 7 Kayachikitsa OPD RK Gupta Marg College road Charkhi Dadri Haryana 127306
Bhiwani
HARYANA 
7054236800

pinkdeep55@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC Shri Krishna Ayush University,Kurukshetra, Haryana   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M95-M95||Other disorders of the musculoskeletal system and connective tissue. Ayurveda Condition: Amvata,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Alambushadi Churna, Reference: Bhaisjya Ratnawali, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -Lukewarm water), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Shatyadi Kashay, Reference: Bhaisjya Ratnawali, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Patients of age group between 30-50 years willing to participate for the trial with a diagnosis of rheumatoid arthritis using theEULAR diagnostic criteria
Diagnosed cases of Amavata based on symptoms and signs described in MadhavNidana.
3. Seropositive and Seronegative both cases are included.
4. Having history of less than 5 years. 
 
ExclusionCriteria 
Details  Patients not willing to participate.
2. Patients having severe deformities.
3. Patients of Gouty Arthritis, Infective Arthritis, Osteoarthritis.
4. HIV, Tuberculosis, Hypertension, D.M., and other major systemic problems.
5. Pregnant & lactating women
6.Patients with major complications such as extra articular manifestations like leg ulcers, digital gangrene, Episcleritis, Endocarditis, pleural and pericardial effusions, neurological and haematologic manifestations etc. will also be excluded.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
ï‚·Both the drugs of the study are expected to be effective because these are mentioned specifically in Amvataprakran in classical text and all constituents are having properties opposite to Ama dosha Vedanashamak and Shothhara  45 days 
 
Secondary Outcome  
Outcome  TimePoints 
ï‚·there can be significant reduction in modern objective parameters like RA factor Anti CCP CRP So effect of Ayurvedic text formulations on Modern parameters can be proved by the study  45 days 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   28/02/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   No 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

A Randomized parallel trial with title " A Clinical Study Of Alambushadi churna and Shatyadi Kashay in patients of Amvata vis-a-vis Rheumatoid Arthritis" in which 100 patients will be taken under 2 groups. Group A consists of Alambushadi Churna 5 gms with lukewarm water  BD for 45 days .Group B contains Alambushadi Churna  5gm BD and Shatyadi Kashay 40 ml BD for 45 days. Follow up period is of 15 days.The components of Alambushadi  Churna are Alambusha Gokshura Haritaki Bhibhitak Amlaki Shunthi Amrita and Shyama root.  Shatyadi Kashay consists of Shati Shunthi Ativisha Vacha Devdaru Guduchi in equal parts. Patient assessment will be done on the basis of subjective and objective criteria and diagnosis according to EULAR criteria.


 
Close